ACTiVION-II, the first of two US Phase 3 clinical trials, did not meet co-primary endpoints of VAS pain score and WOMAC® total score at Month 12Results from ACTiVION-I, the second ...
23hon MSN
Anthropic's Claude extension still contains security vulnerabilities despite multiple updates
Unpatched Claude extension flaws could allow hijacking of Gmail and Google Docs workflows ...
Millions of websites worldwide, including in Australia, are likely vulnerable to a newly revealed pre-authentication RCE.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results